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AnalysisVirus Hunters:
Catching Bugs in the FieldDensely populated areas in rural China require constant vigilance
and state-of-the-art technology to stop new pandemics in their
tracks. Hurdles are not only scientific in some parts of the devel-
oping world.A colony ofMiniopterus schreibersii (Common Bent-winged Bats). The first bat coronavirus
was identified in this species by Leo Lit Man Poon, Malik Peiris, and colleagues in 2005.
Image courtesy of C.T. Shek, Agriculture, Fisheries and Conservation Department, the Hong
Kong Special Administrative Region Government.For more than a decade, farmers in rural
China have suffered from a lethal infection
that causes high fevers, reduces platelet
levels in blood, and sometimes triggers
massive hemorrhages. Based on its clin-
ical presentation, doctors assumed the
diseasewas anaplasmosis, caused by the
bacterium Anaplasma phagocytophilum.
But in 2009, Xue-Jie Yu, researcher at
the University of Texas Medical Branch
and visiting scientist at the Chinese
Center for Disease Control and Preven-
tion (CCDC), noticed something unusual.
Anaplasmosis causes few deaths in the
Western world but was killing nearly three
out of ten patients in China.
Yu is a microbiologist who specializes
in culturing bacteria. The CCDC had
invited Yu to help isolate the anaplasma
bacterium, but following his hunch, Yu
decided to look for a virus. He inoculated
DH82 dog-derived cells with white blood
cells from patients to generate a viral
culture. He was lucky; viruses are picky
about their hosts and only show up
in certain backgrounds. When he saw
diseased cells, he thought, ‘‘Wow, we’ve
got a virus.’’
This was firm proof that the outbreak
was not anaplasmosis. Once Yu had
enough viral particles, he looked at their
morphology under an electron micro-
scope and then sequenced the genome.
He found a novel phlebovirus called
severe fever with thrombocytopenia
syndrome virus (SFTSV) belonging to the
Bunyaviridae family, published this year
in the New England Journal of Medicine.
Since Sept. 2010, 171 patients have
been diagnosed with SFTSV, and 36
have died.
The case has been hailed for the
comparatively short time that it took
Yu and his CCDC colleagues to follow
through on his hunch and characterizethe virus. He had technologies at this
disposal that, a decade ago, would have
been difficult to find in China. And such
technologies remain hard to find in much
of the developing world, leading to a
push for better and cheaper diagnostics
to hunt for emerging viruses.
In the 1960s, flush from the successes
of drug discovery and sanitation, public
health officials had declared mastery
over infectious disease. But over the past
three decades, about 87 new pathogens
causing human disease, most of which
are viruses, have emerged, and nearly
75 percent of these have been zoonoses.
Because environmental changes are
occurring most rapidly in the developing
world, where people and wildlife live in
close proximity but where access to diag-Cell 147, Dnostics is limited, cheaper and better
technologies are of vital importance to
prevent the global spread of diseases.
A Fishing Expedition
Malik Peiris, microbiologist at the Univer-
sity of Hong Kong, and his colleagues,
widely credited with discovering the
SARS coronavirus, have been sequenc-
ing the viral background of bats. They
have found several new coronaviruses,
relying on sequencing machines to hunt
for novel bugs. Bats are excellent reser-
voirs for potentially lethal viruses such as
Nipah, which causes influenza-like illness
in horses and humans. Ecologists capture
bats and stick oral swabs into their
mouths to get a sample of microbes and
send these to Peiris’ lab, where scientists
use either multiplex PCR using family-
wide primers or direct sequencing to find
novel bugs.
If the sequence matches something
in the database, the computer gives a
percent homology. Researchers then
need to show to their best ability that
the isolated virus is indeed causing the
disease and fulfills Koch’s postulates. The
postulates state that the virus must be
present in all patients; the virus derived
from patient samples should be isolated
andcultured; if someone injects the cultureecember 9, 2011 ª2011 Elsevier Inc. 1209
into a healthy patient or animal, the virus
should cause original disease; and when
these new patients are tested, their dis-
ease should be traced to the original bug.
Among viruses causing human disease,
deep sequencing has helped scientists
identify pathogens, including the hemor-
rhagic fever Lujo virus from South Africa
and the Dandenong virus that causes
disease in patients receiving organ trans-
plants.
Still, high-throughput sequencing needs
to be used sparingly, Peiris says.
‘‘Applying deep sequencing for path-
ogen discovery is extremely intensive
and extremely expensive, and if you do
it on every single specimen, it is not
productive,’’ he says. Before sequencing,
researchers need to eliminate possible
known bugs to establish that they are
indeed dealing with something new. And
even before that, front line responders
need to recognize a disease is unusual
and order tests.
‘‘It’s a fishing expedition,’’ says Leo Lit
Man Poon, assistant professor of microbi-
ology at the University of Hong Kong and
part of Peiris’ team. ‘‘You try to sequence
as much as possible hoping that you will
be able to identify some of the sequences
which do not belong to the host.’’
Often, sequences from a patient sam-
ple don’t match anything human, bacte-
rial, or viral in the database.
‘‘This is the black box,’’ says Poon.
Although sequences are being added
to the database at record rates due to
the genomics revolution, the majority
of the world’s organisms—and especially
viruses—have not been sequenced. In
these cases, bioinformaticians use vari-
ous cryptographic methods to figure
out patterns—the frequency at which
some di- or trinucleotides appear, for
example—in the dark matter.
The Virus World on a Chip
Nucleic acid-based microarrays are
becoming so robust and dense that virus
hunters can identify bugs quicker and
cheaper than through high-throughput
sequencing. Even the best sequencers
today take about a day to work through
data, says Ian Lipkin, professor of epide-
miology at the Mailman School of Public
Health at Columbia University.
‘‘Given the price of arrays, the density
of arrays, the fact that you are probably1210 Cell 147, December 9, 2011 ª2011 Elsegoing to be able to survey for all known
viruses for $15 or $20 in the not-too
distant future, and do it in a couple of
hours, is really quite extraordinary,’’ he
says.
Eight to ten million spots can be placed
on a single piece of glass, more than
enough to cover the entire viral world,
says Lipkin. He is collaborating with
Tom Slezak at the Lawrence Livermore
National Laboratory on a Department
of Defense-funded project to generate
universal bacterial and viral microarray
systems that are flexible enough to detect
emerging and variant viruses.
The idea is that, as long as the probes
are well designed, scientists can pick
out an unknown virus whose identity is
suspected at the level of the genus or
family. The microarrays’ first success
was the SARS coronavirus. Whereas
Peiris’ team worked painstakingly to
characterize SARS the old-fashioned
way in Hong Kong, a young researcher
named Joseph DeRisi at the University
of California San Francisco decided to
use a microarray. Without culturing the
virus, he applied respiratory samples from
patients onto the array. Within 24 hr, he
got a positive result corresponding to the
coronavirus family, which was further
confirmedby sequencing results. DeRisi’s
‘‘ViroChip’’ array is now a go-to for virus
hunters. Charles Chiu, also at UCSF, has
used the ViroChip to identify a novel
adenovirus in monkeys and humans and,
most recently, a novel hemorrhagic fever
virus that is yet to be published.
The trend is toward multiplexed
systems on chips, microspheres, and
nanowires. There is talk of further com-
paction, with an array hosting all of the
steps of pathogen discovery, including
sample preparation, PCR, hybridization,
and sequencing.
The upshot is that microarrays will one
day become more portable, cheap, and
easier to use, all of which are needed in
the developing world, where emerging
viruses typically crop up.
‘‘All of these things are going to come
together; they have to, because we need
to have some way to do discovery work
in the field,’’ says Lipkin.
Virus Hunting on the Ground
Most of these sequencing and microarray
technologies are not available beyondvier Inc.a handful of laboratories concentrated in
the West. In the emerging disease hot
spots of the world, including South East
Asia, India, and parts of Africa, basic
PCR tests are the norm if they are
performed at all. Though PCR can help
detect known viruses, the test is too
specific to detect novel bugs.
‘‘Right now, the big issue in the devel-
oping world is there’s very little surveil-
lance being done for any disease,’’ says
Chiu. ‘‘Even for large diseases like malaria
or TB in Africa, there are some cheap
assays, they are not very sensitive, they
are not very specific. There is nothing
there right now.’’
Doctors typically diagnose diseases on
the basis of clinical examinations, and
they do not perform virological tests to
back up their ideas. Most viruses go
undetected. ‘‘A clinical syndrome has
to be diagnosed, has to be noticed, has
to be reported, specimen has to be
collected, specimen has to be sent to
reference laboratories often in Europe or
the United States, which takes a lot
of time,’’ says Heinz Feldmann of the
National Institute of Allergy and Infectious
Diseases. Even then, there may not be
enough quantities of the specimen to
apply on high-throughput technologies,
he says.
Exporting biological samples has also
become challenging following the 9/11
anthrax scares in the United States. Since
the SARS outbreak, the Chinese CCDC
has coped with this barrier by collabo-
rating with researchers like Yu, as well
as experts from the U.S. Centers for
Disease Control and Prevention and
elsewhere. Their national labs are equip-
ped with state-of-the-art high-throughput
diagnostics, including sequencers and
microarrays found in the West.
But given China’s position as an
emerging disease hot spot due to the
proximity between wildlife and people
and its enormous population spread
out over a large area, virus detection
is still challenging. The weakness is
in the hospital system, where diagnos-
tics remain rudimentary, lab technicians
have less training, and doctors rarely
try to identify bugs causing disease,
says Jay Varma, scientist with the New
York City Department of Health and
Mental Hygiene, who helped the CCDC
revamp their system. The expert virus
hunters at CCDC are distanced from the
ground realities of disease in the popula-
tion, he says.
In other parts of the developing
world, corruption and patchy water and
electricity supply can doom the efforts of
virus hunters. Lipkin recalls the time
his graduate student attempted to set
up a basic multiplex PCR system in
Sierra Leone as part of a philanthropicGoogle.org project to help with surveil-
lance in the developing world. The
effort was meant to find novel viruses, as
well as put in place a system for
rapid response to outbreaks. But parts
from the instrument were repeatedly
stolen.
‘‘When people come in and they want
a bribe, and they take the wires from the
instrument, there’s not too much I canCell 147, Ddo about that,’’ says Lipkin. ‘‘That’s not
a failure of technology.’’ACKNOWLEDGMENTS
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